Oric Pharmaceuticals
ORIC
ORIC
112 hedge funds and large institutions have $879M invested in Oric Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 28
1.21% more ownership
Funds ownership: 93.71% → 94.92% (+1.2%)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
112
Holding in Top 10
5
Calls
$3.25M
Puts
$117K
Top Buyers
| 1 | +$55M | |
| 2 | +$27.5M | |
| 3 | +$27.5M | |
| 4 |
VA
VR Adviser
New York
|
+$27M |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$20.6M |
Top Sellers
| 1 | -$27.2M | |
| 2 | -$14.5M | |
| 3 | -$9.07M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$6.07M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.79M |